Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia?

Drug Discovery Today

Volumn 6, Issue 13, 2001, Pages 671-680

  Loetscher, Hansruedi ^a   Niederhauser, Olivier ^a   Kemp, John ^a   Gill, Rammy ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DERIVATIVE; CASPASE; CASPASE 3; CASPASE INHIBITOR; CYTOCHROME C; DIZOCILPINE; DNA FRAGMENT; IDN 5370; KETONE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; APOPTOSIS; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN ISCHEMIA; CELL DEATH; DEGENERATIVE DISEASE; DRUG TARGETING; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; REVIEW; RISK; STROKE;

EID: 0035398570     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01826-8     Document Type: Review

References (107)

1. NMDA receptor antagonists: past disappointments and future prospects as neuroprotective agents
2. A matter of life and cell death
3. Cell death in development
4. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics
5. The changing landscape of ischaemic brain injury mechanisms
6. The central executioners of apoptosis: caspases or mitochondria?
7. Caspases: a decade of death research
8. Caspase structure, proteolytic substrates, and function during apoptotic cell death
9. Caspases: enemies within
10. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases
11. Mammalian caspases: structure, activation, substrates, and functions during apoptosis
12. Serial killers: ordering caspase activation events in apoptosis
13. Biochemical pathways of caspase activation during apoptosis
14. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
15. Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs
16. Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo
17. Mitochondria and apoptosis
18. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis
19. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked
20. Caspase activation without death
21. A caspase-3-like protease is involved in NF-κB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum
22. Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum
23. + efflux and neuronal apoptosis
24. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons
25. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function
26. Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death
27. Calpain and caspase: can you tell the difference?
28. Evidence for hypoxia-induced, programmed cell death of cultured neurons
29. A pathway of neuronal apoptosis induced by hypoxia/reoxygenation: roles of nuclear factor-κB and Bcl-2
30. Caspase inhibitors are functionally neuroprotective against oxygen glucose deprivation induced CA1 death in rat organotypic hippocampal slices
31. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
32. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development
33. Differential requirement for caspase 9 in apoptotic pathways in vivo
34. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
35. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
36. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice
37. Identification of a new caspase homologue: caspase-14
38. Caspase-14 is a novel developmentally regulated protease
39. Molecular cloning and identification of murine caspase-8
40. Cloning and expression of a rat brain interleukin-1 β-converting enzyme (ICE)-related protease (IRP) and its possible role in apoptosis of cultured cerebellar granule neurons
41. Postnatal distribution of cpp32/caspase 3 mRNA in the mouse central nervous system: an in situ hybridization study
42. Changes in caspase expression in Alzheimer's disease: comparison with development and aging
43. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of pathological apoptosis?
44. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation
45. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation
46. Presenilins are processed by caspase-type proteases
47. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract
48. Ultrastructural morphological changes are not characteristic of apoptotic cell death following focal cerebral ischaemia in the rat
49. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures
50. The shape of cell death
51. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts
52. Neuronal death in brain infarcts in man
53. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia
54. DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat
55. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia
56. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity
57. Gene expression induced by cerebral ischemia: an apoptotic perspective
58. Internucleosomal cleavage of DNA as the sole criterion for apoptosis may be artifactual
59. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note
60. Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo
61. Methods for detecting and quantifying apoptosis
62. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases
63. 2+ thresholds that determine survival or death of energy-deprived cells
64. Granzyme B/perforin-mediated apoptosis of Jurkat cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDa fragment
65. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes
66. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death
67. Apoptosis in the absence of poly-(ADP-ribose) polymerase
68. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells
69. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome c and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice
70. Early and sequential recruitment of apoptotic effectors after focal permanent ischemia in mice
71. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats
72. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia
73. Does caspase activation play a role in neuronal damage following focal ischemia induced by permanent middle cerebral artey occlusion?
74. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease
75. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia
76. Activation of CPP-32 protease in hippocampal neurons following ischemia and epilepsy
77. Differential changes of bax, caspase-3 and p21 mRNA expression after transient focal brain ischemia in the rat
78. Caspases as treatment targets in stroke and neurodegenerative diseases
79. Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia
80. Disturbances of cerebral protein synthesis and ischemic cell death
81. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia
82. Histochemical cytochrome c oxidase activity and caspase-3 in gerbil hippocampal CA1 neurons after transient forebrain ischemia
83. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat
84. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation
85. cpp32 messenger RNA neosynthesis is induced by fatal axotomy and is not regulated by athanatal Bcl-2 over-expression
86. Correlation between caspase-3 activation and three different markers of DNA damage in neonatal cerebral hypoxia-ischemia
87. Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia
88. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat
89. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis
90. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines
91. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury
92. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat
93. Inhibition of interleukin 1 β-converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
94. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family
95. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats
96. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia
97. Expression of caspases and their substrates in the rat model of focal cerebral ischemia
98. A caspase inhibitor blocks ischaemia-induced delayed neuronal death in the gerbil
99. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat
100. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex
101. Transient global forebrain ischemia induces a prolonged expression of the caspase-3 mRNA in rat hippocampal CA1 pyramidal neurons
102. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus
103. Topical application of neurotrophin-3 attenuates ischemic brain injury after transient middle cerebral artery occlusion in rats
104. Differential effects of Bcl-2 overexpression on hippocampal CA1 neurons and dentate granule cells following hypoxic ischemia in adult mice
105. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions